Item 2.02. Results of Operations and Financial Condition
On November 8, 2012, Savient Pharmaceuticals, Inc. (the "Registrant") announced
its financial results for the quarter ended September 30, 2012. The full text of
the press release issued in connection with the announcement is furnished as
Exhibit 99.1 to this Current Report on Form 8-K.
In addition, also on November 8, 2012, the Registrant held a publicly available
live webcast discussion of its financial results for the quarter ended September
30, 2012. The transcript of the November 8, 2012 conference call is furnished
as Exhibit 99.2 to this Current Report on Form 8-K.